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Abstract
Background
The 17-item Hamilton Depression Rating Scale (HDRS17) is used world-wide as an
observer-rated measure of depression in randomised controlled trials (RCTs) despite con-
tinued uncertainty regarding its factor structure. This study investigated the dimensionality
of HDRS17 for patients undergoing treatment in UK mental health settings with moderate to
severe persistent major depressive disorder (PMDD).
Methods
Exploratory Structural Equational Modelling (ESEM) was performed to examine the
HDRS17 factor structure for adult PMDD patients with HDRS17 score�16. Participants (n =
187) were drawn from a multicentre RCT conducted in UK community mental health settings
evaluating the outcomes of a depression service comprising CBT and psychopharmacology
within a collaborative care model, against treatment as usual (TAU). The construct stability
across a 12-month follow-up was examined through a measurement equivalence/invariance
(ME/I) procedure via ESEM.
Results
ESEM showed HDRS17 had a bi-factor structure for PMDD patients (baseline mean (sd)
HDRS17 22.6 (5.2); 87% PMDD >1 year) with an overall depression factor and two group fac-
tors: vegetative-worry and retardation-agitation, further complicated by negative item loading.
This bi-factor structure was stable over 12 months follow up. Analysis of the HDRS6 showed
it had a unidimensional structure, with positive item loading also stable over 12 months.
Conclusions
In this cohort of moderate-severe PMDD the HDRS17 had a bi-factor structure stable across
12 months with negative item loading on domain specific factors, indicating that it may be
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more appropriate to multidimensional assessment of settled clinical states, with shorter uni-
dimensional subscales such as the HDRS6 used as measures of change.
Introduction
The 17-item Hamilton Depression Rating Scale (HDRS17), which was developed in late 1950s
has been the most frequently used observer-rated measure of depression for research including
randomised controlled trials (RCTs) of treatments for depression [1–3]. The positive and neg-
ative features of the HDRS17 have been comprehensively reviewed [4–6]. One of its most seri-
ous problems, poor inter-rater and test-retest reliability has been addressed with the
development of the GRID- HDRS17 version [5]. Overall despite its flaws, it continues to be rec-
ommended by licensing and treatment guideline bodies such as the Federal Drug Administra-
tion in the US [7] and the National Institute for Care Excellence [8] because of its longitudinal
continuity for historical comparison in more than 1500 randomised controlled trials, wide-
spread use for meta-analysis and the lack of a superior measure despite many attempts and
considerable resources including the National Institute of Mental Health and the World
Health Organisation [4–6].
However, concerns persist about the widespread use of the of the HDRS17 as a unidimen-
sional measure of depression severity, given indications that it has a more complex factor
structure that is not fully captured by a single, total score [9–13]. Evidence supporting a multi-
dimensional structure has been reviewed by Fried et al [9] and demonstrated across different
methodologies, including hierarchical confirmatory factor analysis (CFA) showing a general
2nd order depression factor [13] and exploratory factor analysis in ‘treatment naïve’ mainly
non-persistent depression [14, 15]. Fried et al [9], went further to show that this multifactorial
structure became more pronounced as depression severity increased, indicating the potential
importance of assessing HDRS17 structure in clearly defined clinical groups identified by levels
of persistence and severity.
In fact, since Hamilton’s original factor analysis [2], relatively little work has been done on
the HDRS17 factor structure in patient groups with more severe, persistent major depressive
disorder (PMDD) under treatment in mental health settings. Findings have instead emerged
from a variety of other clinical settings [11] and populations, including people whose primary
health problem was not depression [12]; and since the nature and complexity of depression
has been shown to vary widely across these populations, including the degree of persistence,
melancholia, anxiety and other associated co-morbidity [16–18], it follows from Fried et al [9]
that these findings cannot be assumed to give a true impression of how the HDRS17 functions
within more severe PMDD. Additionally, methods of statistical analysis have changed over the
60 years since Hamilton’s original work and earlier reports often lacked the more robust ana-
lytical approach now available for establishing factor structure through Exploratory Structural
Equational Modelling (ESEM) [19].
Current modelling via ESEM also allows assessment of the related issue of measurement
invariance, assessed through the consistency of construct measurement across time. Whilst
Fried et al [9] showed this was generally poor for a range of depression measures including the
HDRS17, more recent work using ESEM has shown invariance over 12 months for a patient
completed outcome measure in more severe PMDD (the 9-item Personal Health Questionn-
naire; PHQ-9) [15, 20]. However, there has been no equivalent assessment of clnician outcome
measures, such as the HDRS17 in this PMDD popultation.
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Previous statistical approaches assessing the dimensionality of the HDRS17 have included
both exploratory factor analysis (EFA) and CFA [13]. However, recent literature has shown
that both EFA and CFA have methodological limitations [21, 22]. In EFA modelling it is
impossible to incorporate latent EFA factors into subsequent analyses and it is not easy to test
measure invariance across groups and/or times [22]. In CFA modelling, each item is strictly
allowed to load on one factor and all non-target loadings are constrained to zero. The latest
factor analytical ESEM, integrates the best features of both EFA and CFA together by applying
EFA rigorously to specify more appropriately the underlying factor structure together with the
advanced statistical methods typically associated with CFAs [22]. ESEM allows cross item fac-
tor loadings which are coherent with the underlying theory and/or item contents that item(s)
could cross load on different latent factors; ESEM could reduce the bias in parameter estimates
due to zero loading restriction which generally results in inflated CFA factor correlation
because items might not be perfect factor indicators with some degree of irrelevant association
with other constructs [22–24].
Following on from these findings, in order to explore whether the HDRS17 has a general
depression factor and additional domain specific factors a bi-factor model exploring psycho-
metric multidimensionality within ESEM, is now recommended, rather than the traditional
second order factor analytical model [23, 25, 26]. Compared with hierarchical factor analysis
model (Fig 1), bi-factor models have statistical advantages such as fitting data better and allow-
ing external prediction by group factors with or without overall factors [27]. Conceptually, as
group factors in a bi-factor model are not subsumed by the overall factor [28], they represent
factors explaining items variances which were not accounted for by the overall factor [27].
Therefore the group specific factors have influence over and above the general factor that
might help explain the clinical heterogeneity observed among individual patients with depres-
sion [29], providing valuable clarity for future research and practice.
There is therefore an opportunity and need to re-assess the factor structure and measure-
ment invariance of the HDRS17 in more severe PMDD, made more pressing by the fact that
treatment guidelines, including those currently in preparation [30], continue to use the
HDRS17 as a single total score across a range of depression severity and persistence.
We address this issue here via ESEM bi-factor modelling in a well-defined patient popula-
tion with moderate to severe PMDD, recruited from UK mental health care settings in a previ-
ously published RCT [18], assessing construct stability across 12-month follow-up using a
measurement equivalence/invariance (ME/I) procedure. The chosen 12-month period is
Fig 1. Schematic example of 2nd order factor and bi-factor model: G = general factor, F = group factor.
https://doi.org/10.1371/journal.pone.0241370.g001
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clinically relevant through the extended clinical treatment often necessary in patients with
PMDD.
Materials and methods
Patients and instruments
Patients (N = 187) were drawn from a multicentre pragmatic randomised controlled trial
(RCT) evaluating outcomes of a Special Depression Service (SDS; specialist pharmacotherapy
and psychotherapy within a collaborative care model) against treatment as usual (TAU) within
UK mental health services [18]. At the time of recruitment participants were all adults receiv-
ing community treatment for persistent depression in one of three UK mental health centres
(Nottingham, Derby and Cambridge). Ethics approval was obtained from the Trent Research
Ethics Service in Derby, England. Approval number 09/H0405/42. Oral and written informed
consent was obtained from each participant.
Participants were eligible for the study if they were: thought by the referrer to have primary
unipolar depression; aged 18 years or over; able and willing to give oral and written informed
consent to participate in the study; had been offered or received direct and continuous care
from one or more health professionals in the preceding 6 months and currently be under the
care of a secondary care mental health team; had a diagnosis of major depressive disorder with
a current major depressive episode according to the structured clinical interview for DSM-IV
(SCID) [31]; met five of nine NICE criteria for symptoms of moderate depression; had a score
of�16 on the 17-item GRID version of the Hamilton Depression Rating Scale (HDRS17) [5];
and had a Global Assessment of Functioning (GAF) [32] score� 60. Referrals were excluded if
they: were in receipt of emergency care for suicide risk; were at risk of severe neglect, or posed
a homicide risk, unless that risk was adequately contained in their current care setting; were
not fluent English speakers; were pregnant; had unipolar depression secondary to a primary
psychiatric or medical disorder, except when bipolar disorder was identified by the research
team after referral with unipolar depression because an SDS would be expected to manage
bipolar depression in clinical practice (n = 8, 4.3%).
The mean age of patients was 46.8 years (sd 11.4) and 61.1% (114 of total 187) were female.
Following randomisation 93 (49.7%) patients were allocated to the SDS treatment arm and 94
(50.3%) to treatment as usual (TAU). In the treatment arm, participants received specialist
pharmacological and cognitive behaviour therapy within a collaborative care model structured
and planned over 12 months. TAU comprised multidisciplinary, community-based care deliv-
ered by general mental health services. The primary clinical outcome measure in this trial was
the HDRS17 assessed at baseline, 6 and 12 month follow up time points [33]. One hundred and
sixty-three (87%) participants entering the RCT suffered depression for more than 1 year with
the median (interquartile range) duration of the current episode of 6.5 (2.6–16.0) years. The
mean (sd) severity of the HDRS17 at baseline was 22.6 (5.2) years. Melancholia was present in
105 (56.1%) participants and 146 (78.1%) also had a comorbid anxiety disorder. The study
design, data collection procedures, treatment offered and trial results can be found from the
published protocol [33] and trial report [18].
The HDRS17 evaluates depression severity through items on: 1) depressed mood, 2) guilt,
3) suicidal thought or action, 4) insomnia initial, 5) insomnia middle, 6) insomnia late, 7)
work and interests (assessing pleasure and functioning), 8) motor retardation, 9) motor agi-
tation, 10) psychic anxiety, 11) somatic anxiety, 12) appetite, 13) tiredness, 14) sexual inter-
est, 15) hypochondriasis, 16) weight loss, 17) insight. Among these 17 items, 9 items are
scored on a 5-point scale (0–4) and 8 items on 3-point scale (0–2) with higher scores indicat-
ing greater depressive severity for all items. In keeping with current practice, the total item
PLOS ONE Bi-factor structure of Hamilton Depression Rating Scale
PLOS ONE | https://doi.org/10.1371/journal.pone.0241370 October 26, 2020 4 / 13
score was used to quantify the severity of depression and treatment effect estimates in the
RCT [2].
Statistics
We first examined the frequency of patients’ response on each HDRS17 item across three time
points (baseline, 6 and 12 months). ESEM was then used to explore the factor structure of the
HDRS17 [22]. With reference to existing evidence on the factor structure of the HDRS17, we
tested separately one to five first order factors and also bi-factor models with two-three domain
specific factors for data measured at each time point. Data measured at each time point were
stored in wide format for ESEM modelling with alike items measured at adjacent time corre-
lated to take into account the non-independence of data due to the nature of longitudinal
design [34]. Ordinal item score was analysed with the WLSMV estimator using Delta parame-
terization; missing values were automatically accounted for using the full-information maxi-
mum likelihood approach built into Mplus [35, 36]. Measurement invariance across all follow-
up time points for the best fitted factor structure was further tested using ESEM by comparing
configural invariance model and scalar invariance (item factor loading and item threshold
invariance) model fittings [9, 34, 37]. All ESEM models were performed using software Mplus
8 and in keeping with standard practice correlation between item residuals was set as 0 [37].
Several fitting indices along with chi-square (χ2) test were used to judge model fit as χ2 tests
are sensitive to large sample sizes and non-normal data [38]. The criterion are both compara-
tive fit index (CFI) and the non-normed fit index (NNFI) > 0.90, Root Mean Square Error of
Approximation (RMSEA) < 0.08 [39]. The factor loading and item-factor mapping pattern
were additionally examined by two senior psychiatrists (RM, NN) to make the factor structure
clinically plausible and meaningful. Model comparisons were evaluated by reference to the χ2
change test using Mplus DIFFTEST function to conduct χ2 difference tests, as the WLSMV
estimator was used to analyse ordinal items scores [37]. Since the χ2 change tests are influ-
enced by sample size and data non-normality [34, 40, 41], the CFI change is independent of
both model complexity and sample size and it is not correlated with the overall fit measure-
ments. A reduction of 0.01 or more in CFI suggests the null hypothesis of no difference should
be rejected [41]. We therefore mainly judged model improvement on the CFI change [34, 41]
A number of specific modelling details are presented alongside the results.
Results
Frequency of item response
The frequency of each item by arm across measurement time are presented as an appendix.
There is an extreme response pattern for the item “insight loss”, for which all but one response
was recorded as 0 across measurement time. This extreme response on item “insight loss”
would result in it being excluded from all ESEM modelling due to 0 variability. Hence all
ESEM models in this study were performed using 16 items.
HDRS17 factor structure
Model fitting indices of structure included one to five first order factors and bi-factor models
with two or three domain specific factors for measures at each time (Table 1). Although the
model fitting increased with an increased number of latent factors, the items-factors associa-
tion mapping showed that the bi-factor model with two domain specific factors (bi-2factor)
had the most meaningful factor structure in term of model fitting and item-factor mapping
pattern. A similar pattern was shown when all models in Table 1 were rerun with alike item
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loading set to be equal across measurement time (Table 2). The item-factor association map-
ping also showed that a bi-factor model with two domain specific factors (Table 4) had the
most meaningful factor structure (Table 3). By examining the factor loading pattern shown in
Table 3, it was suggested HDRS17 measured a general depression factor for patients with mod-
erate-severe PMDD, which comprised all items except “motor retardation” together with a
vegetative-worry factor comprising positively loading items “insomnia” (early, middle and
late), ‘weight loss”, “appetite loss” and negative loading items “psychic anxiety” and “hypo-
chondriasis”; and a retardation-agitation factor comprising positive loading items “motor
retardation”, “depressed mood”, diminished pleasure (“work and interests”), “suicidal
thoughts” and negative loading for “agitation”. Item factor loadings for all models shown in
Table 2 are presented as supplementary material (appendix).
Stability of factor structure across measure time
The fitting indices of ME/I test models for configural and scalar invariance across measure-
ment time are presented for comparison in Table 4, indicating that the scalar invariant model
should be retained as the CFI drop is 0.001 with χ2 increase at 147.674 (df = 119), p = 0.038.
These results evidence that the bi-2factor structure is stable through follow up from baseline to
6 and 12 months.
In view of this stable but complex bi-2factor structure, including negative item loadings on
both domain specific factors, we conducted a further post-hoc analysis of the most commonly
used HDRS subscale, the HDRS6 in the same cohort to investigate its potential as an alternative
Table 1. Modelling fitting indices for model with different 1st order and bi-factor structures.
Model χ2(df),p = RMSEA CFI NNFI ΔCFI Δχ2(df),p =
1-factor 1375.249(1045), 0.000 .041 .812 .797
2-factor 1213.822(991), 0.000 .035 .873 .856 .61 159.470(54), 0.000
3-factor 1079.051(934), 0.001 .029 .917 .900 .44 142.193(57), 0.000
Bi-2factor# 1079.051(934), 0.001 .029 .917 .900 142.193(57), 0.000
4-factor 949.400(874), 0.038 .021 .957 .945 .40 139.142(60), 0.000
Bi-3factor# 949.400(874), 0.038 .021 .957 .945 139.142(60), 0.000�
5-factor 839.582(811), 0.236 .014 .984 .977 .27 124.888(63), 0.000
#Bi-2(3) factor model has same fitting indices as 3(4) factor model.
�Comparing with bi-2factor model.
https://doi.org/10.1371/journal.pone.0241370.t001
Table 2. Modelling fitting indices for various models with equal loading across measurement time.
Model χ2(df),p = RMSEA CFI NNFI ΔCFI Δχ2(df),p =
1-factor 1372.823(1075), 0.000 .038 .831 .822
2-factor 1247.154(1047), 0.000 .032 .886 .877 111.539(28), 0.000
3-factor 1143.753(1012), 0.002 .026 .925 .916 .49 106.877(35), 0.000
Bi-2factor# 1143.753(1012), 0.002 .026 .925 .916 .49 106.877(35), 0.000
4-factor 1058.244(970), 0.025 .022 .950 .942 .25 90.859(42), 0.000
Bi-3factor# 1058.244(970), 0.025 .022 .950 .942 .25 90.859(42), 0.000�
5-factor 969.202(921), 0.131 .017 .973 .966 .17 103.371(49), 0.000
#Bi-2(3) factor model has same fitting indices as 3(4) factor model.
�Comparing with bi-2factor model.
https://doi.org/10.1371/journal.pone.0241370.t002
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change measure to the full HDRS17 in moderate-severe PMDD [42]. The HDRS6 comprises 6
items: depressed mood, work and interests (pleasure), general somatic (tiredness), psychic anxi-
ety, guilt feelings and psychomotor retardation; and since it was not plausible to perform an
exploratory analysis testing a model with 1 to 3 factors on a 6-item scale, we instead used a one
factor model to test its unidimensional factor structure. Results given in Tables 5 and 6 show
that all 6 items of the HDRS6 subscale loaded positively and significantly, with time invariance;
supporting this as a stable, unidimensional outcome measure in moderate-severe PMDD, in
contrast to the 17-item scale.
Discussion
In light of findings that the HDRS17 is not a unidimensional measure of depression [9, 14, 43,
44], that the factor structure may differ between clinical populations [9] and may not be stable
over time, we aimed to assess the HDRS17 in a well-defined group of patients with moderate to
severe PMDD, using contemporary ESEM modelling. Consistent with much of this earlier
work, our results in moderate-severe PMDD showed that the HDRS17 had a bi-factor, rather
than unidimensional structure. We additionally showed that this structure was time-invariant
through the full 12-month period of study. The bi-factor structure comprised a general depres-
sion factor and two domain specific factors, which we refer to as ‘vegetative-worry’ and ‘retar-
dation-agitation’. The bi-factor structure was further complicated by the two domain specific
factors including both positively and negatively loading items, problematising use of the
HDRS17 as an outcome measure in moderate to severe PMDD–even allowing for multiple
Table 4. Fitting indices of ME/I across measurement time.
Model χ2(df),p = RMSEA CFI NNFI ΔCFI Δχ2(df),p =
Configural 1079.051(934), 0.001 .029 .917 .900
Scalar 1201.002(1053),0.001 .027 .916 .910 .001 147.674 (119), p = 0.038
https://doi.org/10.1371/journal.pone.0241370.t004
Table 3. Factor loading of best fitted model.
Item Vegetative Worry General depression Retardation Agitation
depressed mood -0.072 0.440 0.342
guilt feeling -0.069 0.391 0.130
suicidal thoughts -0.006 0.381 0.260
insomnia initial 0.478 0.181 -0.018
insomnia middle 0.636 0.239 0.072
insomnia delayed 0.465 0.192 0.043
work & interests 0.111 0.380 0.322
motor retardation 0.097 0.054 0.601
Agitation -0.036 0.336 -0.366
psychic anxiety -0.302 0.546 -0.003
somatic anxiety -0.098 0.486 0.008
appetite decrease 0.281 0.399 -0.070
Tiredness 0.07 0.519 0.069
sexual interest -0.008 0.268 0.122
Hypochondriasis -0.259 0.328 -0.106
weight loss 0.386 0.352 -0.351
# estimate in bold statistically significant at p<0.05.
https://doi.org/10.1371/journal.pone.0241370.t003
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domain scoring within a bi-factor structure, we are left with the problem of incorporating
domain factor items with opposite directionality. This problem was previously encountered
within development of the 6-item subscale (HDRS6) where agitation was excluded due to
reciprocal interaction with the other items [45]; and opposite directionality cannot be surpris-
ing when applying the GRID-HDRS17 to severe PMDD, when severe retardation is described
by as ‘all movements very slowed’ and severe agitation as ‘cannot sit still. . .pacing’ [5].
Given these findings on the complex multidimensional structure of the HDRS17 in moder-
ate-severe PMDD and the associated question of its legitimacy as an outcome measure for this
patient group, we ran a further post-hoc analysis of the most commonly used 6-item subscale
to test its dimensionality and potential as an alternative measure of change to the 17-item scale
[42]. The HDRS6 subscale was derived through item analysis of the HDRS17 against global
assessment of depression by experienced psychiatrists and it has already demonstrated a unidi-
mensional structure in some clinical populations [43, 45]. Our results confirm this unidimen-
sionality in moderate-severe PMDD, additionally showing time-invariance over 12 months;
supporting use of the HDRS6 as an appropriate outcome measure in this group. In contrast
our findings on the HDRS17 do not support its use in this way.
What then for the 17-item scale? Firstly, it seems likely that this was initially conceived as a
state measure, rather than a measure of change [2]. It’s more complex structure, including con-
cepts now understood as near polar opposites (e.g. agitation and retardation as operationalised
in the GRID-HDRS17) may still be more relevant to the assessment of settled clinical states,
where the domain factors we have identified may further clarify depression type, acting as pre-
dictor variables to assist development of treatment strategies [45]. A patient loading high on
worry (psychic anxiety, hypochondriasis) rather than vegetative disturbance (sleep, appetite,
weight), may for example benefit from more targeted initial clinical interventions reflecting
this delineated state rather than non-specific depression treatments [46]. The HDRS17 might
then be repeated later on for this individual, not as a measure of change, but to re-conceptual-
ise a later settled state (such as a limited but stable treatment response) in order to develop
next-step treatment strategies–in this model outcome change would be assessed through more
parsimonious, evidence-based item-sets, such as the HDRS6.
Table 5. Factor loading for HDRS6 subscale.
Item HDRS6
Depressed Mood .544�
Work and Interests .526�
General Somatic (Tiredness) .474�
Psychic Anxiety .417�
Guilt Feelings .396�
Psychomotor retardation .407�
� all loading estimates statistically significant at p<0.01.
https://doi.org/10.1371/journal.pone.0241370.t005
Table 6. Fitting indices of ME/I across measurement time, HDRS6 subscale.
Model χ2(df),p = RMSEA CFI NNFI ΔCFI Δχ2(df),p =
Configural 193.266(120),0.000 .057 .934 .913
Scalar a 459.218(165),0.000 .098 .736 .755 259.790(45), p = 0.000
Scalar b� 229.625(146),0.000 .055 .925 .921 -.009 44.883(26), p = 0.012
� scalar b model freed 24 of 55 (43%) threshold parameters estimates.
https://doi.org/10.1371/journal.pone.0241370.t006
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This approach seems in keeping with the initial history of the Hamilton scale. An awareness
of the multidimensionality of the HDRS17 dates back 60 years to Hamilton’s original work,
also based in observations on patients suffering severe depression within mental health treat-
ment; identifying four hierarchical factors (“general”, “endogenous”, “anxious” and “insom-
nia”) that show parallels with the bi-factor model derived here; including a main “general
depression” factor, a retarded-depressed factor, a broadly vegetative factor and a separate fac-
tor including psychic anxiety [2]. Subsequent use of the HDRS17 to report a single, total item
score risks missing the potential richness and purpose of this scale; confirmed again by the
ESEM structure presented here. Similarly, use of the HDRS17 to measure change seems both
unintended and unsupported by the growing evidence base.
The strengths of our study include a well characterised sample; the systematic application
of a standardised interview version of the HDRS17; the multicentre design; and assessment
over three-time intervals across 12 months with adequate retention. The systematic application
of both psychiatric and psychological treatment over this time period in one group versus
usual care provided both a test of the robustness of the factor structure of the HDRS17 and data
from a broad group within UK mental health service care. Analysis included the first use of the
most advanced ESEM modelling which allows cross factor loading and bi-factor modelling to
simultaneously explore the overall latent factor and specific sub-factors for PMDD patients
HDRS17 measures, incorporating the ME/I test of invariance [22, 23, 40].
Our findings on the HDRS17 and HDRS6 are however limited to a single UK cohort of
patients with moderate-severe PMDD. Given previous findings that factor structure may
change with clinical characteristics of depression, such as severity [9], our findings do not pre-
sume that the same structure holds for other populations with less persistent, complex or
severe depression. This caution fits with recognised features of PMDD, such as rumination/
worry [47] and high comorbidity (e.g. 78.1% of the current cohort had a separate anxiety dis-
order), which may not be present in less severe, less persistent depression. Equally, psychomo-
tor disturbance (through agitation or retardation) identified within our PMDD cohort may be
much less prevalent in patients recruited from primary care or other general medical settings
[1, 17]. It seems quite plausible in this regard that a different factor structure may emerge in
these different clinical groups and whilst our preliminary findings in PMDD remain impor-
tant, they cannot be assumed to generalise. Rather, important differences between clinical
groups may be reflected in real changes to the underlying factor structure of the measurement
tool, accounting for some observed differences between this and earlier studies conducted in
predominately non-persistent depression [14]. Other important limitations include: the lack
of a specific power calculation for the purposes of the current analysis [18, 33], though its size
was sufficient to perform factor analysis modelling based in previous work on the methodol-
ogy used here [48]; and the 40 per cent attrition over 12 months follow up, though again this
left a sufficient sample for invariance analysis.
Data from the current study could be meta-analysed in future with other studies with simi-
lar designs and analysis methods to provide more robust results on the HDRS17 factor struc-
ture in patients with moderate-severe PMDD.
Conclusions
These preliminary findings in patients with moderate-severe PMDD indicate the HDRS17 has
a bi-factorial structure characterised by a general depression factor with two additional factors,
‘vegetative-worry’ and ‘retardation-agitation’. This conceptual structure was found to be rela-
tively stable across a 12-month follow up period but negative item loading on the HDRS17
domain specific factors does not support its use as an outcome measure in this clinical
PLOS ONE Bi-factor structure of Hamilton Depression Rating Scale
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population. Instead, the HDRS17 may be more appropriate in the multidimensional assess-
ment of settled clinical states, helping to guide targeted interventions; with shorter unidimen-
sional subscales such as the HDRS6 used as measures of change.
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